Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03748134
Title Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma (ORIENT-15)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications

esophagus squamous cell carcinoma

Therapies

Cisplatin + Fluorouracil

Cisplatin + Fluorouracil + Sintilimab

Cisplatin + Paclitaxel

Cisplatin + Paclitaxel + Sintilimab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.